Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EDI048 in a Cryptosporidium Controlled Human Infection Model (CHIM) in Healthy Participants
NCT07249463Phase 2Recruiting
- Sponsor
- Novartis
- Start
- Dec 2025
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
A Phase 2 trial of KDU 731 in cryptosporidiosis, sponsored by Novartis. Started Dec 2025; status: recruiting.
02
Drugs
KDU 731
03
Conditions
cryptosporidiosis
Beyond the preview
Go deeper on NCT07249463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07249463.